Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers

SARS-CoV-2 infection is known to lead to severe morbidity and mortality in patients with liver cirrhosis. For this reason, vaccination of these patients against COVID-19 is widely recommended. However, data regarding immunogenicity in patients with liver cirrhosis is limited and even less is known a...

Descripción completa

Detalles Bibliográficos
Autores principales: Willuweit, Katharina, Frey, Alexandra, Passenberg, Moritz, Korth, Johannes, Saka, Nissrin, Anastasiou, Olympia E., Möhlendick, Birte, Schütte, Andreas, Schmidt, Hartmut, Rashidi-Alavijeh, Jassin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949848/
https://www.ncbi.nlm.nih.gov/pubmed/35335009
http://dx.doi.org/10.3390/vaccines10030377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949848/
https://www.ncbi.nlm.nih.gov/pubmed/35335009
http://dx.doi.org/10.3390/vaccines10030377

Ejemplares similares